Cognyte Software Ltd. (CGNT): Intelligence with Data AnalyticsCognyte Software Ltd. (CGNT) specializes in providing advanced security analytics software to help organizations address complex security challenges. The company focuses on leveraging big data and artificial intelligence to deliver actionable insights for government agencies and enterprises worldwide. Cognyte’s tools are designed to support threat detection, investigation, and response, making it a key player in enhancing public safety and corporate security.
Cognyte’s stock chart recently showed a confirmation bar with increasing volume, signaling renewed investor interest. This bar also moved into the momentum zone, indicating a potential shift toward a stronger upward trend. The combination of fundamental strength and positive technical signals makes Cognyte an interesting stock to watch.
81M trade ideas
RiskMastery's Breakout Stocks - CGNT EditionWelcome to RiskMastery's Breakout Stocks - Stocks with breakout potential.
In this edition, we'll be looking at NASDAQ:CGNT ...
I believe this code is at a point of potential volatility.
If price can hold above $7.08 ... Bullish potential may be unlocked.
My key upside targets include:
- $8.65 (Conservative)
- $11.30 (Medium)
- $13.49 (Aggressive)
If however price falls below $5.33 ... Bearish risk potential may be unlocked.
(My key risk targets - C, M,& A - are as noted on the chart)
Enjoy, and I look forward to being of further service into the future.
If you'd like to connect, feel free to reach out and comment below.
Mr RM | Risk Mastery
Disclaimer:
This post is intended for educational purposes only - Publicly available RiskMastery information & content is not intended to be financial advice in any shape or form. Please do your own research and seek advice from a licensed professional before acting on any of the information contained within this post. This post is not a solicitation or recommendation to buy, sell or hold any positions in any financial instrument. All demonstrated trades are merely incidental to the educational training RiskMastery aims to provide. You are solely responsible for your own investment and trading decisions, of which should be made only according to your own opinion, knowledge and experience. You should not rely on any of the information contained on this site or contained in any RiskMastery material on any website or platform. You assume the sole risk of any trade or investment you elect to make. RiskMastery and affiliates shall not be liable to you for any monetary losses or any other damages incurred directly or indirectly, from your use, reliance or reference of RiskMastery materials, content and educational information. Thank you for your understanding and cooperation - We look forward to working with you into the future to navigate the fine line of trading and investment success.
September Trades (CGNT, BUY, 9.12-9.12, 10%)Cognyte Announces Second Quarter Fiscal 2024 Results, Increases Full-Year Outlook
Cognyte (CGNT) reported a loss of $0.09 per share on revenue of $77.05 million for the fiscal second quarter ended July 2023. The consensus EPS estimate was a loss of $0.21 per share and revenue estimate was $76.22 million.
The company said it now expects a fiscal year non-GAAP loss of approximately $0.33 per share on revenue of $300.9 million to $313.1 million. The company's previous guidance was a loss of approximately $0.53 per share on revenue of $296.9 million to $309.1 million for the year ending January 31, 2024.
Cognyte is a global leader in security analytics software that empowers governments and enterprises with Actionable Intelligence for a Safer World™.
CGNT Cognyte Software Options Ahead of EarningsAnalyzing the options chain of CGNT Cognyte Software prior to the earnings report this week,
I would consider purchasing the 7.50usd strike price in the money Calls with
an expiration date of 2024-1-19,
for a premium of approximately $0.67.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Looking forward to read your opinion about it.
CGNT Possible brakout formationOver the past few months CGNT has exhibited a constant uptrend. Initially, it broke out of the original ascending triangle (Blue Lines) and ran for about 5 days until buyers locked in their profits and sold, causing a retest of the 13EMA. Moreover, the stock is riding the 13EMA upwards. I believe that the stock will reach resistance at (3.36) within the next few days (yellow lines). Also expect another re-test of the 13EMA if the market opens lower than the close as sellers would rather lock in some profits than stick around to find out what happens. Furthermore, I would not buy into the stock till the resistance level is reached as to eliminate the possibility of this being a false breakout.
CGNTCogentix Medical Inc. (CGNT) topped out in the mid-20s in 2005 and tested that resistance level in 2008. It then entered a severe downtrend that continued into the May 2016 all-time low at 71-cents. Price action since that time has carved a multi-leg recovery, with the stock recently bouncing off new support at the 200-day EMA under $2.00. Pullbacks to the blue trendline and 50-day EMA near $2.00 should be buyable, ahead of a test at the 2016 high and continued uptrend.